SNPs
A miRNA-492 binding-site polymorphism in BSG (basigin) confers risk to psoriasis in central south Chinese population.
Wu LS, Li FF, Sun LD, Li D, Su J, Kuang YH, Chen G, Chen XP, Chen X.
Hum Genet. 2011 Dec;130(6):749-57.
Alterations of microRNAs contribute to colon carcinogenesis.
Schetter AJ, Harris CC.
Semin Oncol. 2011 Dec;38(6):734-42.
Association between single-nucleotide polymorphisms in pre-miRNAs and the risk of asthma in a Chinese population.
Su XW, Yang Y, Lv ML, Li LJ, Dong W, Miao-Liao, Gao LB, Luo HB, Yun-Liu, Cong RJ, Liang WB, Li YB.
DNA Cell Biol. 2011 Nov;30(11):919-23.
A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck.
Liu Z, Wei S, Ma H, Zhao M, Myers JN, Weber RS, Sturgis EM, Wei Q.
Carcinogenesis. 2011 Nov;32(11):1668-74.
No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population:
a case-control study.
Akkız H, Bayram S, Bekar A, Akgöllü E, Usküdar O, Sandıkçı M.
Gene. 2011 Oct 15;486(1-2):104-9.
Polymorphisms in miRNA binding site: new insight into small cell lung cancer susceptibility.
Liu HY, Chen J.
Acta Pharmacol Sin. 2011 Oct;32(10):1191-2.
Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study.
Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR.
Twin Res Hum Genet. 2011 Oct;14(5):417-21.
Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes Project.
Mu XJ, Lu ZJ, Kong Y, Lam HY, Gerstein MB.
Nucleic Acids Res. 2011 Sep 1;39(16):7058-76.
Inferring causative variants in microRNA target sites.
Thomas LF, Saito T, Sætrom P.
Nucleic Acids Res. 2011 Sep 1;39(16):e109.
Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility.
Chen AX, Yu KD, Fan L, Li JY, Yang C, Huang AJ, Shao ZM.
PLoS Genet. 2011 Sep;7(9):e1002259.
SNPs in microRNA binding sites in 3'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction.
Nossent AY, Hansen JL, Doggen C, Quax PH, Sheikh SP, Rosendaal FR.
Am J Hypertens. 2011 Sep;24(9):999-1006.
Genetic changes of miR-182 G106A: rather a polymorphism than a somatic mutation.
Damm F, Markus B, Thol F, Heuser M, Ganser A, Krauter J.
Ann Hematol. 2011 Sep;90(9):1107-9.
Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast
cancer risk and calcification.
Zhang L, Liu Y, Song F, Zheng H, Hu L, Lu H, Liu P, Hao X, Zhang W, Chen K.
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13653-8.
miRNAs in the spotlight: Making 'silent' mutations speak up.
Salzman DW, Weidhaas JB.
Nat Med. 2011 Aug 4;17(8):934-5.
A SNP in the miR-27a gene is associated with litter size in pigs.
Lei B, Gao S, Luo LF, Xia XY, Jiang SW, Deng CY, Xiong YZ, Li FE.
Mol Biol Rep. 2011 Aug;38(6):3725-9.
Haplotyping of putative microRNA-binding sites in the SNAP-25 gene.
Kovacs-Nagy R, Sarkozy P, Hu J, Guttman A, Sasvari-Szekely M, Ronai Z.
Electrophoresis. 2011 Aug;32(15):2013-20.
[Association of human microRNA related genetic variations with cancer].
Li PY, He FC, Zhou GQ.
Yi Chuan. 2011 Aug;33(8):870-8.
A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a
case-control study.
Akkız H, Bayram S, Bekar A, Akgöllü E, Ulger Y.
J Viral Hepat. 2011 Jul;18(7):e399-407.
Genetic study of two single nucleotide polymorphisms within corresponding microRNAs and susceptibility to tuberculosis in a Chinese
Tibetan and Han population.
Li D, Wang T, Song X, Qucuo M, Yang B, Zhang J, Wang J, Ying B, Tao C, Wang L.
Hum Immunol. 2011 Jul;72(7):598-602.
Association between SNPs in pre-miRNA and risk of chronic obstructive pulmonary disease.
Li LJ, Gao LB, Lv ML, Dong W, Su XW, Liang WB, Zhang L.
Clin Biochem. 2011 Jul;44(10-11):813-6.
A single nucleotide polymorphism in a miR-1302 binding site in CGA increases the risk of idiopathic male infertility.
Zhang H, Liu Y, Su D, Yang Y, Bai G, Tao D, Ma Y, Zhang S.
Fertil Steril. 2011 Jul;96(1):34-39.e7.
Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population.
Yue C, Wang M, Ding B, Wang W, Fu S, Zhou D, Zhang Z, Han S.
Gynecol Oncol. 2011 Jul;122(1):33-7.
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D; BCFR
Investigators, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, Brewster W, Brooks-Wilson A, Brown R, Butzow R, Caldes
T, Caligo MA, Campbell I, Chang-Claude J, Chen YA, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Despierre E, Doherty JA, Dörk
T, Dürst M, Eccles DM, Ekici AB, Easton D; EMBRACE Investigators, Fasching PA, de Fazio A, Fenstermacher DA, Flanagan JM, Fridley
BL, Friedman E, Gao B, Sinilnikova O; GEMO Study Collaborators, Gentry-Maharaj A, Godwin AK, Goode EL, Goodman MT, Gross J,
Hansen TV, Harnett P, Rookus M; HEBON Investigators, Heikkinen T, Hein R, Høgdall C, Høgdall E, Iversen ES, Jakubowska A, Johnatty
SE, Karlan BY, Kauff ND, Kaye SB, Chenevix-Trench G; kConFab Investigators and the Consortium of Investigators of Modifiers of
BRCA1/2, Kelemen LE, Kiemeney LA, Kjaer SK, Lambrechts D, Lapolla JP, Lázaro C, Le ND, Leminen A, Leunen K, Levine DA, Lu Y,
Lundvall L, Macgregor S, Marees T, Massuger LF, McLaughlin JR, Menon U, Montagna M, Moysich KB, Narod SA, Nathanson KL,
Nedergaard L, Ness RB, Nevanlinna H, Nickels S, Osorio A, Paul J, Pearce CL, Phelan CM, Pike MC, Radice P, Rossing MA, Schildkraut
JM, Sellers TA, Singer CF, Song H, Stram DO, Sutphen R, Lindblom A; SWE-BRCA Investigators, Terry KL, Tsai YY, van Altena AM,
Vergote I, Vierkant RA, Vitonis AF, Walsh C, Wang-Gohrke S, Wappenschmidt B, Wu AH, Ziogas A, Berchuck A, Risch HA; Ovarian
Cancer Association Consortium.
Clin Cancer Res. 2011 Jun 1;17(11):3742-50.
LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Bloom G, Chanock SJ, Chen Z, Cramer DW, Cunningham
JM, Dagne G, Ebbert-Syfrett J, Fenstermacher D, Fridley BL, Garcia-Closas M, Gayther SA, Ge W, Gentry-Maharaj A, Gonzalez-Bosquet
J, Goode EL, Iversen E, Jim H, Kong W, McLaughlin J, Menon U, Monteiro AN, Narod SA, Pharoah PD, Phelan CM, Qu X, Ramus SJ,
Risch H, Schildkraut JM, Song H, Stockwell H, Sutphen R, Terry KL, Tyrer J, Vierkant RA, Wentzensen N, Lancaster JM, Cheng JQ, Sellers
TA; Ovarian Cancer Association Consortium.
Cancer Res. 2011 Jun 1;71(11):3896-903.
A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer
risk.
Wang F, Hu Z, Yang R, Tang J, Liu Y, Hemminki K, Sutter C, Wappenschmidt B, Niederacher D, Arnold N, Meindl A, Bartram CR,
Schmutzler RK, Burwinkel B, Shen H.
Breast Cancer Res Treat. 2011 Jun;127(3):769-75.
Sequence variants within the 3'-UTR of the COL5A1 gene alters mRNA stability: implications for musculoskeletal soft tissue injuries.
Laguette MJ, Abrahams Y, Prince S, Collins M.
Matrix Biol. 2011 Jun;30(5-6):338-45.
A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.
Luo X, Yang W, Ye DQ, Cui H, Zhang Y, Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, Tak PP, Tsao BP, Shen N.
PLoS Genet. 2011 Jun;7(6):e1002128.
Analysis of CYP3A4 genetic polymorphisms in Han Chinese.
Zhou Q, Yu X, Shu C, Cai Y, Gong W, Wang X, Wang DM, Hu S.
J Hum Genet. 2011 Jun;56(6):415-22.
miRvar: A comprehensive database for genomic variations in microRNAs.
Bhartiya D, Laddha SV, Mukhopadhyay A, Scaria V.
Hum Mutat. 2011 Jun;32(6):E2226-45.
Association of the HLA-G gene +3142C>G polymorphism with systemic lupus erythematosus.
Consiglio CR, Veit TD, Monticielo OA, Mucenic T, Xavier RM, Brenol JC, Chies JA.
Tissue Antigens. 2011 Jun;77(6):540-5.
Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk.
Yang R, Dick M, Marme F, Schneeweiss A, Langheinz A, Hemminki K, Sutter C, Bugert P, Wappenschmidt B, Varon R, Schott S, Weber
BH, Niederacher D, Arnold N, Meindl A, Bartram CR, Schmutzler RK, Müller H, Arndt V, Brenner H, Sohn C, Burwinkel B.
Breast Cancer Res Treat. 2011 Jun;127(2):549-54.
Ambient pollutants, polymorphisms associated with microRNA processing and adhesion molecules: the Normative Aging Study.
Wilker EH, Alexeeff SE, Suh H, Vokonas PS, Baccarelli A, Schwartz J.
Environ Health. 2011 May 21;10:45.
[Association of miR-605 and miR-149 genetic polymorphisms with related risk factors of lung cancer susceptibility].
Zhang MW, Yu YX, Jin MJ, Pan YF, Jiang X, Li QL, Ma XY, Zhang SC, Chen K.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011 May;40(3):265-71.
Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population.
Hong YS, Kang HJ, Kwak JY, Park BL, You CH, Kim YM, Kim H.
J Prev Med Public Health. 2011 May;44(3):125-30.
Polymorphisms in microRNA targets: a source of new molecular markers for male reproduction.
Ogorevc J, Dovc P, Kunej T.
Asian J Androl. 2011 May;13(3):505-8.
An insertion/deletion polymorphism in the 3' untranslated region of type I collagen a2 (COL1A2) is associated with susceptibility for
hepatocellular carcinoma in a Chinese population.
Zhu Z, Jiang Y, Chen S, Jia S, Gao X, Dong D, Gao Y.
Cancer Genet. 2011 May;204(5):265-9.
The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site.
Richardson K, Louie-Gao Q, Arnett DK, Parnell LD, Lai CQ, Davalos A, Fox CS, Demissie S, Cupples LA, Fernandez-Hernando C,
Ordovas JM.
PLoS One. 2011 Apr 20;6(4):e17944.
Copy number variation of microRNA genes in the human genome.
Marcinkowska M, Szymanski M, Krzyzosiak WJ, Kozlowski P.
BMC Genomics. 2011 Apr 12;12:183.
Combined effect of miR-146a rs2910164 G/C polymorphism and Toll-like receptor 4 +3725 G/C polymorphism on the risk of severe
gastric atrophy in Japanese.
Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N.
Dig Dis Sci. 2011 Apr;56(4):1131-7.
KRAS 3'-UTR variants and stratification of breast-cancer risk.
Kumar MS, Swanton C.
Lancet Oncol. 2011 Apr;12(4):318-9.
Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies.
Chu H, Wang M, Shi D, Ma L, Zhang Z, Tong N, Huo X, Wang W, Luo D, Gao Y, Zhang Z.
PLoS One. 2011 Mar 31;6(3):e18108.
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma.
Godshalk SE, Paranjape T, Nallur S, Speed W, Chan E, Molinaro AM, Bacchiocchi A, Hoyt K, Tworkoski K, Stern DF, Sznol M, Ariyan S,
Lazova R, Halaban R, Kidd KK, Weidhaas JB, Slack FJ.
Oncogene. 2011 Mar 31;30(13):1542-50.
Molecular genetics: The sound of silence.
Hurst LD.
Nature. 2011 Mar 31;471(7340):582-3.
Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival.
Hu Z, Shu Y, Chen Y, Chen J, Dong J, Liu Y, Pan S, Xu L, Xu J, Wang Y, Dai J, Ma H, Jin G, Shen H.
Am J Respir Crit Care Med. 2011 Mar 1;183(5):641-8.
[Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma].
Zhang XW, Pan SD, Feng YL, Liu JB, Dong J, Zhang YX, Chen JG, Hu ZB, Shen HB.
Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Mar;45(3):239-43.
Genetic variation in microRNA genes and prostate cancer risk in North Indian population.
George GP, Gangwar R, Mandal RK, Sankhwar SN, Mittal RD.
Mol Biol Rep. 2011 Mar;38(3):1609-15.
A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's
disease.
Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier JF, Hébuterne X, Harel-Bellan A,
Mograbi B, Darfeuille-Michaud A, Hofman P.
Nat Genet. 2011 Mar;43(3):242-5.
A C/T mutation in microRNA target sites in BMP5 gene is potentially associated with fatness in pigs.
Shao GC, Luo LF, Jiang SW, Deng CY, Xiong YZ, Li FE.
Meat Sci. 2011 Mar;87(3):299-303.
Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-
deprivation therapy.
Bao BY, Pao JB, Huang CN, Pu YS, Chang TY, Lan YH, Lu TL, Lee HZ, Juang SH, Chen LM, Hsieh CJ, Huang SP.
Clin Cancer Res. 2011 Feb 15;17(4):928-36.
Using bioinformatics to predict the functional impact of SNVs.
Cline MS, Karchin R.
Bioinformatics. 2011 Feb 15;27(4):441-8.
dPORE-miRNA: polymorphic regulation of microRNA genes.
Schmeier S, Schaefer U, MacPherson CR, Bajic VB.
PLoS One. 2011 Feb 4;6(2):e16657.
A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population.
Zhan JF, Chen LH, Chen ZX, Yuan YW, Xie GZ, Sun AM, Liu Y.
Arch Med Res. 2011 Feb;42(2):144-8.
Possible involvement of microRNAs (miR-135a∗) in heart failure associated with 25bp deletion in MYBPC3 (cardiac myosin binding
protein C) gene.
Uppugunduri CR.
Med Hypotheses. 2011 Feb;76(2):306.
Evaluation of polymorphisms in predicted target sites for micro RNAs differentially expressed in endometriosis.
Zhao ZZ, Croft L, Nyholt DR, Chapman B, Treloar SA, Hull ML, Montgomery GW.
Mol Hum Reprod. 2011 Feb;17(2):92-103.
Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer.
Lheureux S, Lambert B, Krieger S, Legros A, Vaur D, Denoyelle C, Berthet P, Poulain L, Hardouin A.
Breast Cancer Res Treat. 2011 Feb;125(3):885-91.
Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives.
Ceolotto G, Papparella I, Bortoluzzi A, Strapazzon G, Ragazzo F, Bratti P, Fabricio AS, Squarcina E, Gion M, Palatini P, Semplicini A.
Am J Hypertens. 2011 Feb;24(2):241-6.
Single point mutation of microRNA may cause butterfly effect on alteration of global gene expression.
Lee HC, Yang CW, Chen CY, Au LC.
Biochem Biophys Res Commun. 2011 Jan 28;404(4):1065-9.
A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular
carcinoma.
Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, Liu S, Liu Z, Shi H, Shen H, Hu Z.
Int J Cancer. 2011 Jan 15;128(2):412-7.
The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB, Tang M, Zhang LS, Wei YG, Zhang L.
Breast Cancer Res Treat. 2011 Jan;125(2):571-4.
Polymorphisms in predicted miRNA binding sites and osteoporosis.
Lei SF, Papasian CJ, Deng HW.
J Bone Miner Res. 2011 Jan;26(1):72-8.
A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with
metastatic colorectal cancer treated with cetuximab monotherapy.
Zhang W, Winder T, Ning Y, Pohl A, Yang D, Kahn M, Lurje G, Labonte MJ, Wilson PM, Gordon MA, Hu-Lieskovan S, Mauro DJ, Langer C,
Rowinsky EK, Lenz HJ.
Ann Oncol. 2011 Jan;22(1):104-9.
A functional variant of IC53 correlates with the late onset of colorectal cancer.
Chen J, Shi Y, Li Z, Yu H, Han Y, Wang X, Sun K, Yang T, Lou K, Song Y, Zhang Y, Zhen Y, Zhang G, Hu Y, Ji J, Hui R.
Mol Med. 2011;17(7-8):607-18.
Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis.
Xu W, Xu J, Liu S, Chen B, Wang X, Li Y, Qian Y, Zhao W, Wu J.
PLoS One. 2011;6(5):e20471.
Screening SNPs residing in the microRNA-binding sites of hepatocellular carcinoma related genes.
Ding J, Gao Y, He Y, Zhou Y, Huang M, Liu H.
Int J Data Min Bioinform. 2011;5(1):1-21.
Prediction of the biological effect of polymorphisms within microRNA binding sites.
Landi D, Barale R, Gemignani F, Landi S.
Methods Mol Biol. 2011;676:197-210.
The glypican 3-hosted murine mir717 gene: sequence conservation, seed region polymorphisms and putative targets.
Kunej T, Skok DJ, Horvat S, Dovc P, Jiang Z.
Int J Biol Sci. 2010 Dec 2;6(7):769-72.
MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.
Blitzblau RC, Weidhaas JB.
Mol Diagn Ther. 2010 Dec 1;14(6):335-42.
An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
Wynendaele J, Böhnke A, Leucci E, Nielsen SJ, Lambertz I, Hammer S, Sbrzesny N, Kubitza D, Wolf A, Gradhand E, Balschun K, Braicu I,
Sehouli J, Darb-Esfahani S, Denkert C, Thomssen C, Hauptmann S, Lund A, Marine JC, Bartel F.
Cancer Res. 2010 Dec 1;70(23):9641-9.
[MiR-196a-2 gene polymorphism and the antiviral therapy of chronic hepatitis C].
Hong XL, Cao H, Zhao F, Pan XF, Zhang K, Xu QH, Zhao ZX, Li G.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 Dec;24(6):470-2.
Assessing the effect of the CLPG mutation on the microRNA catalog of skeletal muscle using high-throughput sequencing.
Caiment F, Charlier C, Hadfield T, Cockett N, Georges M, Baurain D.
Genome Res. 2010 Dec;20(12):1651-62.
A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform.
Xu Y, Liu H, Li F, Sun N, Ren Y, Liu Z, Cao X, Wang Y, Liu P, Zhang K.
J Affect Disord. 2010 Dec;127(1-3):332-6.
Functional genetic variants in the 3'-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity.
Yu X, Dhakal IB, Beggs M, Edavana VK, Williams S, Zhang X, Mercer K, Ning B, Lang NP, Kadlubar FF, Kadlubar S.
Toxicol Sci. 2010 Dec;118(2):391-403.
Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population.
Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T, Hirata I.
Helicobacter. 2010 Dec;15(6):524-31.
Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer
patients.
Pastrello C, Polesel J, Della Puppa L, Viel A, Maestro R.
Carcinogenesis. 2010 Dec;31(12):2124-6.
A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population.
Dou T, Wu Q, Chen X, Ribas J, Ni X, Tang C, Huang F, Zhou L, Lu D.
J Cancer Res Clin Oncol. 2010 Dec;136(12):1853-9.
[Progress of polymorphism in microRNA and microRNA target sites].
Liu LY, Xu JR, Song TS, Huang C.
Yi Chuan. 2010 Nov;32(11):1091-6.
A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han.
Wang K, Guo H, Hu H, Xiong G, Guan X, Li J, Xu X, Yang K, Bai Y.
Biomarkers. 2010 Nov;15(7):614-8.
MicroSNiPer: a web tool for prediction of SNP effects on putative microRNA targets.
Barenboim M, Zoltick BJ, Guo Y, Weinberger DR.
Hum Mutat. 2010 Nov;31(11):1223-32.
Genetic variants and abnormal processing of pre-miR-182, a circadian clock modulator, in major depression patients with late insomnia.
Saus E, Soria V, Escaramís G, Vivarelli F, Crespo JM, Kagerbauer B, Menchón JM, Urretavizcaya M, Gratacòs M, Estivill X.
Hum Mol Genet. 2010 Oct 15;19(20):4017-25.
Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck.
Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM, Wei Q.
Cancer. 2010 Oct 15;116(20):4753-60.
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients
treated with salvage cetuximab-irinotecan.
Graziano F, Canestrari E, Loupakis F, Ruzzo A, Galluccio N, Santini D, Rocchi M, Vincenzi B, Salvatore L, Cremolini C, Spoto C,
Catalano V, D'Emidio S, Giordani P, Tonini G, Falcone A, Magnani M.
Pharmacogenomics J. 2010 Oct;10(5):458-64.
Looking for microRNA polymorphisms as new rheumatoid arthritis risk loci?
Apparailly F.
Joint Bone Spine. 2010 Oct;77(5):377-9.
A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with
rheumatoid arthritis susceptibility.
Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA.
Joint Bone Spine. 2010 Oct;77(5):411-3.
Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma.
Lin J, Horikawa Y, Tamboli P, Clague J, Wood CG, Wu X.
Carcinogenesis. 2010 Oct;31(10):1805-12.
Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with
polymorphic fibrinogen alpha gene.
Chen Z, Nakajima T, Tanabe N, Hinohara K, Sakao S, Kasahara Y, Tatsumi K, Inoue Y, Kimura A.
Hum Genet. 2010 Oct;128(4):443-52.
Human SP-A1 (SFTPA1) variant-specific 3' UTRs and poly(A) tail differentially affect the in vitro translation of a reporter gene.
Silveyra P, Wang G, Floros J.
Am J Physiol Lung Cell Mol Physiol. 2010 Oct;299(4):L523-34.
A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.
Olsson M, Norgren N, Obayashi K, Plante-Bordeneuve V, Suhr OB, Cederquist K, Jonasson J.
BMC Med Genet. 2010 Sep 14;11:130.
Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy.
Zhou B, Rao L, Peng Y, Wang Y, Chen Y, Song Y, Zhang L.
Clin Chim Acta. 2010 Sep 6;411(17-18):1287-90.
Recent progress in genetic variants associated with cancer and their implications in diagnostics development.
Cho WC.
Expert Rev Mol Diagn. 2010 Sep;10(6):699-703.
MicroRNA binding site polymorphisms as biomarkers of cancer risk.
Pelletier C, Weidhaas JB.
Expert Rev Mol Diagn. 2010 Sep;10(6):817-29.
Demonstrating polymorphic miRNA-mediated gene regulation in vivo: application to the g+6223G->A mutation of Texel sheep.
Takeda H, Charlier C, Farnir F, Georges M.
RNA. 2010 Sep;16(9):1854-63.
Alteration of processing induced by a single nucleotide polymorphism in pri-miR-126.
Harnprasopwat R, Ha D, Toyoshima T, Lodish H, Tojo A, Kotani A.
Biochem Biophys Res Commun. 2010 Aug 20;399(2):117-22.
Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk
women.
Kontorovich T, Levy A, Korostishevsky M, Nir U, Friedman E.
Int J Cancer. 2010 Aug 1;127(3):589-97.
Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population.
Srivastava K, Srivastava A, Mittal B.
J Hum Genet. 2010 Aug;55(8):495-9.
Exclusion of sequence polymorphisms in the porcine ITGA5 and MIR148B loci as causal variation for congenital splay leg in piglets.
Maak S, Boettcher D, Komolka K, Tetens J, Wimmers K, Reinsch N, Swalve HH, Thaller G.
Anim Genet. 2010 Aug;41(4):447-8.
Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population.
Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, Cheng Q.
Dig Dis Sci. 2010 Aug;55(8):2288-93.
Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population.
Zeng Y, Sun QM, Liu NN, Dong GH, Chen J, Yang L, Wang B.
World J Gastroenterol. 2010 Jul 28;16(28):3578-83.
FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients.
de Mena L, Cardo LF, Coto E, Miar A, Díaz M, Corao AI, Alonso B, Ribacoba R, Salvador C, Menéndez M, Morís G, Alvarez V.
Neurosci Lett. 2010 Jul 19;479(1):22-5.
Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer.
Christensen BC, Avissar-Whiting M, Ouellet LG, Butler RA, Nelson HH, McClean MD, Marsit CJ, Kelsey KT.
Clin Cancer Res. 2010 Jul 15;16(14):3713-20.
KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer.
Nelson HH, Christensen BC, Plaza SL, Wiencke JK, Marsit CJ, Kelsey KT.
Lung Cancer. 2010 Jul;69(1):51-3.
A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population.
Kim MJ, Yoo SS, Choi YY, Park JY.
Lung Cancer. 2010 Jul;69(1):127-9.
Black carbon exposures, blood pressure, and interactions with single nucleotide polymorphisms in MicroRNA processing genes.
Wilker EH, Baccarelli A, Suh H, Vokonas P, Wright RO, Schwartz J.
Environ Health Perspect. 2010 Jul;118(7):943-8.
Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer.
Lee HC, Kim JG, Chae YS, Sohn SK, Kang BW, Moon JH, Jeon SW, Lee MH, Lim KH, Park JY, Choi GS, Jun SH.
J Cancer Res Clin Oncol. 2010 Jul;136(7):1073-8.
A functional variant in the 3'-UTR of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microRNA 211.
Chen J, Yang T, Yu H, Sun K, Shi Y, Song W, Bai Y, Wang X, Lou K, Song Y, Zhang Y, Hui R.
Hum Mol Genet. 2010 Jun 15;19(12):2524-33.
A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, Wappenschmidt B, Volkmann J, Varon R, Weber BH, Niederacher D, Arnold N,
Meindl A, Bartram CR, Schmutzler RK, Burwinkel B.
Breast Cancer Res Treat. 2010 Jun;121(3):693-702.
Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus
infection.
Qi P, Dou TH, Geng L, Zhou FG, Gu X, Wang H, Gao CF.
Hum Immunol. 2010 Jun;71(6):621-6.
Analysis of a polymorphic microRNA target site in the purinergic receptor P2RX7 gene.
Rahman OA, Sasvari-Szekely M, Szekely A, Faludi G, Guttman A, Nemoda Z.
Electrophoresis. 2010 Jun;31(11):1790-5.
MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia.
Xu Y, Li F, Zhang B, Zhang K, Zhang F, Huang X, Sun N, Ren Y, Sui M, Liu P.
Schizophr Res. 2010 Jun;119(1-3):219-27.
Genetic variation in microRNA networks: the implications for cancer research.
Ryan BM, Robles AI, Harris CC.
Nat Rev Cancer. 2010 Jun;10(6):389-402.
A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new
form of dominant X-linked chondrodysplasia.
Simon D, Laloo B, Barillot M, Barnetche T, Blanchard C, Rooryck C, Marche M, Burgelin I, Coupry I, Chassaing N, Gilbert-Dussardier B,
Lacombe D, Grosset C, Arveiler B.
Hum Mol Genet. 2010 May 15;19(10):2015-27.
Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.
Zhou X, Chen X, Hu L, Han S, Qiang F, Wu Y, Pan L, Shen H, Li Y, Hu Z.
Gynecol Oncol. 2010 May;117(2):287-90.
Genetic variation in FGF20 modulates hippocampal biology.
Lemaitre H, Mattay VS, Sambataro F, Verchinski B, Straub RE, Callicott JH, Kittappa R, Hyde TM, Lipska BK, Kleinman JE, McKay R,
Weinberger DR.
J Neurosci. 2010 Apr 28;30(17):5992-7.
Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, Wojcik SE, Ferdin J, Kunej T, Xiao L, Manoukian S, Secreto G,
Ravagnani F, Wang X, Radice P, Croce CM, Davuluri RV, Calin GA.
Cancer Res. 2010 Apr 1;70(7):2789-98.
A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo.
Xu B, Feng NH, Li PC, Tao J, Wu D, Zhang ZD, Tong N, Wang JF, Song NH, Zhang W, Hua LX, Wu HF.
Prostate. 2010 Apr 1;70(5):467-72.
Single nucleotide polymorphism associated with nonsyndromic cleft palate influences the processing of miR-140.
Li L, Meng T, Jia Z, Zhu G, Shi B.
Am J Med Genet A. 2010 Apr;152A(4):856-62.
Polymorphisms in the putative micro-RNA-binding sites of mesothelin gene are associated with serum levels of mesothelin-related protein.
Cristaudo A, Foddis R, Bonotti A, Simonini S, Vivaldi A, Guglielmi G, Bruno R, Landi D, Gemignani F, Landi S.
Occup Environ Med. 2010 Apr;67(4):233-6.
Short communication: genetic variability in the predicted microRNA target sites of caprine casein genes.
Zidi A, Amills M, Tomás A, Vidal O, Ramírez O, Carrizosa J, Urrutia B, Serradilla JM, Clop A.
J Dairy Sci. 2010 Apr;93(4):1749-53.
An improved in silico selection of phenotype affecting polymorphisms in SLC6A4, HTR1A and HTR2A genes.
Piva F, Giulietti M, Nardi B, Bellantuono C, Principato G.
Hum Psychopharmacol. 2010 Mar;25(2):153-61.
miRNA mutations are not a common cause of deafness.
Hildebrand MS, Witmer PD, Xu S, Newton SS, Kahrizi K, Najmabadi H, Valle D, Smith RJ.
Am J Med Genet A. 2010 Mar;152A(3):646-52.
Novel genetic variants in miR-191 gene and familial ovarian cancer.
Shen J, DiCioccio R, Odunsi K, Lele SB, Zhao H.
BMC Cancer. 2010 Feb 18;10:47.
Design and evaluation of a panel of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human
disease.
Muiños-Gimeno M, Montfort M, Bayés M, Estivill X, Espinosa-Parrilla Y.
Eur J Hum Genet. 2010 Feb;18(2):218-26.
Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer.
Wojcik SE, Rossi S, Shimizu M, Nicoloso MS, Cimmino A, Alder H, Herlea V, Rassenti LZ, Rai KR, Kipps TJ, Keating MJ, Croce CM,
Calin GA.
Carcinogenesis. 2010 Feb;31(2):208-15.
An insertion/deletion polymorphism in the 3' untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with
susceptibility for hepatocellular carcinoma in Chinese.
Chen S, He Y, Ding J, Jiang Y, Jia S, Xia W, Zhao J, Lu M, Gu Z, Gao Y.
Biochem Biophys Res Commun. 2010 Jan 1;391(1):552-6.
Common genetic variants in pre-microRNAs are associated with risk of coal workers' pneumoconiosis.
Wang M, Ye Y, Qian H, Song Z, Jia X, Zhang Z, Zhou J, Ni C.
J Hum Genet. 2010 Jan;55(1):13-7.
Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases.
Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, Hemminki K, Sutter C, Wappenschmidt B, Dick M, Arnold N, Bugert P,
Niederacher D, Meindl A, Schmutzler RK, Bartram CC, Ficarazzi F, Tizzoni L, Zaffaroni D, Manoukian S, Barile M, Pierotti MA, Radice P,
Burwinkel B, Peterlongo P.
Hum Mutat. 2010 Jan;31(1):E1052-7.
Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates.
Hiard S, Charlier C, Coppieters W, Georges M, Baurain D.
Nucleic Acids Res. 2010 Jan;38(Database issue):D640-51.
MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.
Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, Bertino JR.
PLoS One. 2009 Dec 24;4(12):e8445.
A computation to integrate the analysis of genetic variations occurring within regulatory elements and their possible effects.
Wu LC, Horng JT, Chen YA.
J Comput Biol. 2009 Dec;16(12):1731-47.
Identification of intergenic trans-regulatory RNAs containing a disease-linked SNP sequence and targeting cell cycle
progression/differentiation pathways in multiple common human disorders.
Glinskii AB, Ma J, Ma S, Grant D, Lim CU, Sell S, Glinsky GV.
Cell Cycle. 2009 Dec;8(23):3925-42.
An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for
hepatocellular carcinoma.
Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, Wu Y, Guo B, Shen Y, Landi D, Landi S, Zhou Y, Liu H.
Carcinogenesis. 2009 Dec;30(12):2064-9.
Rs5848 variant influences GRN mRNA levels in brain and peripheral mononuclear cells in patients with Alzheimer's disease.
Fenoglio C, Galimberti D, Cortini F, Kauwe JS, Cruchaga C, Venturelli E, Villa C, Serpente M, Scalabrini D, Mayo K, Piccio LM, Clerici F,
Albani D, Mariani C, Forloni G, Bresolin N, Goate AM, Scarpini E.
J Alzheimers Dis. 2009 Nov;18(3):603-12.
An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of
breast cancer onset.
Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen K.
Clin Cancer Res. 2009 Oct 1;15(19):6292-300.
A genome-wide survey of copy number variations in Han Chinese residing in Taiwan.
Lin CH, Lin YC, Wu JY, Pan WH, Chen YT, Fann CS.
Genomics. 2009 Oct;94(4):241-6.
A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis.
Saetrom P, Biesinger J, Li SM, Smith D, Thomas LF, Majzoub K, Rivas GE, Alluin J, Rossi JJ, Krontiris TG, Weitzel J, Daly MB, Benson
AB, Kirkwood JM, O'Dwyer PJ, Sutphen R, Stewart JA, Johnson D, Larson GP.
Cancer Res. 2009 Sep 15;69(18):7459-65.
Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes.
Duan S, Mi S, Zhang W, Dolan ME.
RNA Biol. 2009 Sep-Oct;6(4):412-25.
SNPs in human miRNA genes affect biogenesis and function.
Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA, Sommer SS, Rossi JJ.
RNA. 2009 Sep;15(9):1640-51.
APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease.
Bettens K, Brouwers N, Engelborghs S, Van Miegroet H, De Deyn PP, Theuns J, Sleegers K, Van Broeckhoven C.
Hum Mutat. 2009 Aug;30(8):1207-13.
Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population.
Xu J, Hu Z, Xu Z, Gu H, Yi L, Cao H, Chen J, Tian T, Liang J, Lin Y, Qiu W, Ma H, Shen H, Chen Y.
Hum Mutat. 2009 Aug;30(8):1231-6.
Insights into the importance of miRNA-related polymorphisms to heart disease.
Clop A.
Hum Mutat. 2009 Aug;30(8):v.
SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies.
Xu Z, Taylor JA.
Nucleic Acids Res. 2009 Jul 1;37(Web Server issue):W600-5.
Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site.
Feinberg-Gorenshtein G, Avigad S, Jeison M, Halevy-Berco G, Mardoukh J, Luria D, Ash S, Steinberg R, Weizman A, Yaniv I.
Genes Chromosomes Cancer. 2009 Jul;48(7):539-43.
Genomic sequence matters: a SNP in microRNA-146a can turn anti-apoptotic.
Jazdzewski K, de la Chapelle A.
Cell Cycle. 2009 Jun 1;8(11):1642-3.
Genetic variation in LIN28B is associated with the timing of puberty.
Ong KK, Elks CE, Li S, Zhao JH, Luan J, Andersen LB, Bingham SA, Brage S, Smith GD, Ekelund U, Gillson CJ, Glaser B, Golding J,
Hardy R, Khaw KT, Kuh D, Luben R, Marcus M, McGeehin MA, Ness AR, Northstone K, Ring SM, Rubin C, Sims MA, Song K, Strachan
DP, Vollenweider P, Waeber G, Waterworth DM, Wong A, Deloukas P, Barroso I, Mooser V, Loos RJ, Wareham NJ.
Nat Genet. 2009 Jun;41(6):729-33.
MicroRNAs and genomic variations: from Proteus tricks to Prometheus gift.
Fabbri M, Valeri N, Calin GA.
Carcinogenesis. 2009 Jun;30(6):912-7.
A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.
Christensen BC, Moyer BJ, Avissar M, Ouellet LG, Plaza SL, McClean MD, Marsit CJ, Kelsey KT.
Carcinogenesis. 2009 Jun;30(6):1003-7.
Germline mutation of microRNA-125a is associated with breast cancer.
Li W, Duan R, Kooy F, Sherman SL, Zhou W, Jin P.
J Med Genet. 2009 May;46(5):358-60.
An ENU-induced mutation of miR-96 associated with progressive hearing loss in mice.
Lewis MA, Quint E, Glazier AM, Fuchs H, De Angelis MH, Langford C, van Dongen S, Abreu-Goodger C, Piipari M, Redshaw N, Dalmay
T, Moreno-Pelayo MA, Enright AJ, Steel KP.
Nat Genet. 2009 May;41(5):614-8.
Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss.
Mencía A, Modamio-Høybjør S, Redshaw N, Morín M, Mayo-Merino F, Olavarrieta L, Aguirre LA, del Castillo I, Steel KP, Dalmay T,
Moreno F, Moreno-Pelayo MA.
Nat Genet. 2009 May;41(5):609-13.
Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression.
Kim J, Bartel DP.
Nat Biotechnol. 2009 May;27(5):472-7.
dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation.
Hariharan M, Scaria V, Brahmachari SK.
BMC Bioinformatics. 2009 Apr 16;10:108.
Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504.
Huang W, Li MD.
Biol Psychiatry. 2009 Apr 15;65(8):702-5.
A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human
behaviors.
Jensen KP, Covault J, Conner TS, Tennen H, Kranzler HR, Furneaux HM.
Mol Psychiatry. 2009 Apr;14(4):381-9.
A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese.
Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G, Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y, Shen H.
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1183-7.
Human genome connectivity code links disease-associated SNPs, microRNAs and pyknons.
Glinsky GV.
Cell Cycle. 2009 Mar 15;8(6):925-30.
Novel genetic variants in microRNA genes and familial breast cancer.
Shen J, Ambrosone CB, Zhao H.
Int J Cancer. 2009 Mar 1;124(5):1178-82.
Mechanistic insights into the link between a polymorphism of the 3'UTR of the SLC7A1 gene and hypertension.
Yang Z, Kaye DM.
Hum Mutat. 2009 Mar;30(3):328-33.
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.
Mishra PJ, Bertino JR.
Pharmacogenomics. 2009 Mar;10(3):399-416.
A dominant mutation in DCL1 suppresses the hyl1 mutant phenotype by promoting the processing of miRNA.
Tagami Y, Motose H, Watanabe Y.
RNA. 2009 Mar;15(3):450-8.
Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer.
Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, de la Chapelle A.
Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1502-5.
Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women.
Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, Miao R, Wang Y, Wang X, Shen H.
Hum Mutat. 2009 Jan;30(1):79-84.
A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal
women.
Tchatchou S, Jung A, Hemminki K, Sutter C, Wappenschmidt B, Bugert P, Weber BH, Niederacher D, Arnold N, Varon-Mateeva R, Ditsch
N, Meindl A, Schmutzler RK, Bartram CR, Burwinkel B.
Carcinogenesis. 2009 Jan;30(1):59-64.
A large-scale survey of genetic copy number variations among Han Chinese residing in Taiwan.
Lin CH, Li LH, Ho SF, Chuang TP, Wu JY, Chen YT, Fann CS.
BMC Genet. 2008 Dec 24;9:92.
Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma.
Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y, Gu J, Lin J, Habuchi T, Wu X.
Clin Cancer Res. 2008 Dec 1;14(23):7956-62.
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia.
Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ, Finch N, Rutherford NJ, Crook RJ, Josephs KA, Boeve BF,
Knopman DS, Petersen RC, Parisi JE, Caselli RJ, Wszolek ZK, Uitti RJ, Feldman H, Hutton ML, Mackenzie IR, Graff-Radford NR, Dickson
DW.
Hum Mol Genet. 2008 Dec 1;17(23):3631-42.
Disease phenocode analysis identifies SNP-guided microRNA maps (MirMaps) associated with human "master" disease genes.
Glinsky GV.
Cell Cycle. 2008 Dec;7(23):3680-94.
Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk.
Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, Wu X.
Cancer Prev Res (Phila Pa). 2008 Nov;1(6):460-9.
A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.
Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, Yang JR, Su H, Zhuang SM.
Carcinogenesis. 2008 Nov;29(11):2126-31.
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller RU, Straka E, Su L, Burki EA, Crowell RE, Patel R, Kulkarni T, Homer R,
Zelterman D, Kidd KK, Zhu Y, Christiani DC, Belinsky SA, Slack FJ, Weidhaas JB.
Cancer Res. 2008 Oct 15;68(20):8535-40.
First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with
diarrhea predominant irritable bowel syndrome.
Kapeller J, Houghton LA, Mönnikes H, Walstab J, Möller D, Bönisch H, Burwinkel B, Autschbach F, Funke B, Lasitschka F, Gassler N,
Fischer C, Whorwell PJ, Atkinson W, Fell C, Büchner KJ, Schmidtmann M, van der Voort I, Wisser AS, Berg T, Rappold G, Niesler B.
Hum Mol Genet. 2008 Oct 1;17(19):2967-77.
MicroRNA target site polymorphisms and human disease.
Sethupathy P, Collins FS.
Trends Genet. 2008 Oct;24(10):489-97.
A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H.
Carcinogenesis. 2008 Oct;29(10):1963-6.
Allele-specific targeting of hsa-miR-657 to human IGF2R creates a potential mechanism underlying the association of ACAA-
insertion/deletion polymorphism with type 2 diabetes.
Lv K, Guo Y, Zhang Y, Wang K, Jia Y, Sun S.
Biochem Biophys Res Commun. 2008 Sep 12;374(1):101-5.
Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
Wu M, Jolicoeur N, Li Z, Zhang L, Fortin Y, L'Abbe D, Yu Z, Shen SH.
Carcinogenesis. 2008 Sep;29(9):1710-6.
An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal
components of the nuclear import pathway.
Glinsky GV.
Cell Cycle. 2008 Aug 15;7(16):2570-83.
[Identification of SNPs located in putative microRNA tar-get region of six functional genes in chickens through bioinformatic analysis]
Geng LY, Zhang CS, DU LX.
Yi Chuan. 2008 Aug;30(8):1026-32.
Functional genetic variation of human miRNAs and phenotypic consequences.
Borel C, Antonarakis SE.
Mamm Genome. 2008 Aug;19(7-8):503-9.
ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs.
Smirnov DA, Cheung VG.
Am J Hum Genet. 2008 Aug;83(2):243-53.
Genetic variants of miRNA sequences and non-small cell lung cancer survival.
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, Zeng Y, Miao R, Jin G, Ma H, Chen Y, Shen H.
J Clin Invest. 2008 Jul;118(7):2600-8.
Polymorphisms in microRNA targets: a gold mine for molecular epidemiology.
Chen K, Song F, Calin GA, Wei Q, Hao X, Zhang W.
Carcinogenesis. 2008 Jul;29(7):1306-11.
Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.
Brendle A, Lei H, Brandt A, Johansson R, Enquist K, Henriksson R, Hemminki K, Lenner P, Försti A.
Carcinogenesis. 2008 Jul;29(7):1394-9.
Mutation of miRNA target sequences during human evolution.
Gardner PP, Vinther J.
Trends Genet. 2008 Jun;24(6):262-5.
Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma.
Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A.
Proc Natl Acad Sci U S A. 2008 May 20;105(20):7269-74.
Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X.
Cancer Res. 2008 Apr 1;68(7):2530-7.
MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.
Mishra PJ, Mishra PJ, Banerjee D, Bertino JR.
Cell Cycle. 2008 Apr;7(7):853-8.
Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
Landi D, Gemignani F, Naccarati A, Pardini B, Vodicka P, Vodickova L, Novotny J, Försti A, Hemminki K, Canzian F, Landi S.
Carcinogenesis. 2008 Mar;29(3):579-84.
Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas.
Yang J, Zhou F, Xu T, Deng H, Ge YY, Zhang C, Li J, Zhuang SM.
Mutat Res. 2008 Feb 1;638(1-2):205-9.
Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.
Wang G, van der Walt JM, Mayhew G, Li YJ, Züchner S, Scott WK, Martin ER, Vance JM.
Am J Hum Genet. 2008 Feb;82(2):283-9.
A catalog of polymorphisms falling in microRNA-binding regions of cancer genes.
Landi D, Gemignani F, Barale R, Landi S.
DNA Cell Biol. 2008 Jan;27(1):35-43.
Joint annotation of coding and non-coding single nucleotide polymorphisms and mutations in the SNPeffect and PupaSuite databases.
Reumers J, Conde L, Medina I, Maurer-Stroh S, Van Durme J, Dopazo J, Rousseau F, Schymkowitz J.
Nucleic Acids Res. 2008 Jan;36(Database issue):D825-9.
Allele-specific targeting of microRNAs to HLA-G and risk of asthma.
Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D, Ober C.
Am J Hum Genet. 2007 Oct;81(4):829-34.
The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding.
Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS.
J Biol Chem. 2007 Aug 17;282(33):24262-9.
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance.
Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D, Bertino JR.
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13513-8.
Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a
mechanism for functional single-nucleotide polymorphisms related to phenotypes.
Sethupathy P, Borel C, Gagnebin M, Grant GR, Deutsch S, Elton TS, Hatzigeorgiou AG, Antonarakis SE.
Am J Hum Genet. 2007 Aug;81(2):405-13.
A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male
subjects.
Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Hasegawa S, Takagi T, Wang FY, Hirata I, Nakano H.
Dig Dis Sci. 2007 Jul;52(7):1691-7.
Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease.
Georges M, Coppieters W, Charlier C.
Curr Opin Genet Dev. 2007 Jun;17(3):166-76.
Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA.
Duan R, Pak C, Jin P.
Hum Mol Genet. 2007 May 1;16(9):1124-31.
Human polymorphism at microRNAs and microRNA target sites.
Saunders MA, Liang H, Li WH.
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3300-5.
PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits.
Bao L, Zhou M, Wu L, Lu L, Goldowitz D, Williams RW, Cui Y.
Nucleic Acids Res. 2007 Jan;35(Database issue):D51-4.
Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers.
Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, Wang E, Wu M, Shen SH.
Nucleic Acids Res. 2007;35(13):4535-41.
Natural selection on human microRNA binding sites inferred from SNP data.
Chen K, Rajewsky N.
Nat Genet. 2006 Dec;38(12):1452-6.
RDMAS: a web server for RNA deleterious mutation analysis.
Shu W, Bo X, Liu R, Zhao D, Zheng Z, Wang S.
BMC Bioinformatics. 2006 Sep 6;7:404.
A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep.
Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibe B, Bouix J, Caiment F, Elsen JM, Eychenne F, Larzul C, Laville E, Meish F,
Milenkovic D, Tobin J, Charlier C, Georges M.
Nat Genet. 2006 Jul;38(7):813-8.
Overgrowth caused by misexpression of a microRNA with dispensable wild-type function.
Nairz K, Rottig C, Rintelen F, Zdobnov E, Moser M, Hafen E.
Dev Biol. 2006 Mar 15;291(2):314-24.
A microdeletion in Xp11.3 accounts for co-segregation of retinitis pigmentosa and mental retardation in a large kindred.
Zhang L, Wang T, Wright AF, Suri M, Schwartz CE, Stevenson RE, Valle D.
Am J Med Genet A. 2006 Feb 15;140(4):349-57.
Polymorphic microRNA-target interactions: a novel source of phenotypic variation.
Georges M, Clop A, Marcq F, Takeda H, Pirottin D, Hiard S, Tordoir X, Caiment F, Meish F, Bibe B, Bouix J, Elsen JM, Eychenne F,
Laville E, Larzul C, Milenkovic D, Tobin J, Charlier AC.
Cold Spring Harb Symp Quant Biol. 2006;71:343-50.
Sequence variants in SLITRK1 are associated with Tourette's syndrome.
Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-
Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LS 4th, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N,
State MW.
Science. 2005 Oct 14;310(5746):317-20.
Regulatory mutations of mir-48, a C. elegans let-7 family MicroRNA, cause developmental timing defects.
Li M, Jones-Rhoades MW, Lau NC, Bartel DP, Rougvie AE.
Dev Cell. 2005 Sep;9(3):415-22.
Polymorphisms in human pre-miRNAs.
Iwai N, Naraba H.
Biochem Biophys Res Commun. 2005 Jun 17;331(4):1439-44.